2019年4期
刊物介紹
本刊主要是及時報道我國在腫瘤防治研究領(lǐng)域包括癌癥基礎(chǔ)理論研究和癌癥預防、臨床治療研究方面的新進展、新成果，內(nèi)容涉及腫瘤病因?qū)W與滸病學，實驗腫瘤學、腫瘤細胞分子生物學，腫瘤病理學以及腫瘤影像診斷、腫瘤外科治療、化學治療、放射治療、介入治療、生物治療和中西醫(yī)結(jié)合治療腫瘤等各分支學科，旨在促進國內(nèi)外學術(shù)交流，提高我國癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
- Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version)
- Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)
- An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress?
- Association of cancer prevention awareness with esophageal cancer screening participation rates: Results from a populationbased cancer screening program in rural China
- FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma
- Clinical significance of MET gene amplification in metastatic or locally advanced gastric cancer treated with first-line fluoropyrimidine and platinum combination chemotherapy
- A 18FDG PET/CT-based volume parameter is a predictor of overall survival in patients with local advanced gastric cancer
- Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer
- Changing patterns and survival improvements of young breast cancer in China and SEER database, 1999-2017
- Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China
- Evaluation of COC183B2 antibody targeting ovarian cancer by near-infrared fluorescence imaging
- An enrichment model using regular health examination data for early detection of colorectal cancer
- Identification of cancer patients using claims data from health insurance systems: A real-world comparative study